Financial incentives provided to hospitals in Japan led to a significant increase in biosimilar oncology drug prescriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback